GI Stool Testing Market – By Product Type (Reagents and Kits, Instruments and Analyzers, Software, and Services), By Test (Microscopy Test, Ovum Parasite Test, Culture Test, Bacteria Test, Occult Blood Test (Guaiac Fob Stool Test, Immuno-Fob Agglutination Test, Lateral Flow Immuno-Fob Test, Immuno-Fob Elisa Test), Stool Biomarkers Test (Cologuard, M2-Pk Stool Test), By Application, (Infection, Inflammatory Bowel Disease (IBD), Gastroesophageal Reflux Disease, Cancer, Others), By Distribution Channel ( Hospitals & Clinics Pharmacies, Brick & Mortar, E-Commerce), By End User (Hospital, Diagnostic Centre and Laboratory, Academic Institution, Research Centre Organization, Homecare, Others), By Geography - Opportunity Analysis & Industry Forecast, 2024-2030.

Report Code: HCR 58744 Report Format: PDF + Excel

GI Stool Testing Market Overview:

The GI Stool Testing Market size is estimated to reach $932.8 million by 2030, growing at a CAGR of 7.7% during the forecast period 2024-2030. The growing prevalence of GI illnesses and growing awareness of gastrointestinal health are driving significant growth in the GI stool testing market. The market environment is being driven by the growing number of baby boomers who are experiencing gastrointestinal disorders, which has increased demand for diagnostic techniques.

Additionally, the accuracy and dependability of GI stool tests have been improved by developments in diagnostic technology, such as molecular diagnostics and non-invasive testing techniques, which are major contributors to this expansion. These advancements improve patient outcomes by enabling the early diagnosis of diseases like inflammatory bowel disease (IBD), IBS, and colorectal cancer. More accurate diagnostic options are made possible by the introduction of stool DNA and fecal immunochemical assays (FIT), which is propelling market expansion even further. All things considered, the market for GI stool testing is expected to increase significantly due to the following factors: growing healthcare programs focused at early diagnosis and preventative care; rising prevalence of GI illnesses; and technical advancements.

Market Snapshot: 

Image
GI Stool Testing Market - Report Coverage:

The “GI Stool Testing Market Report - Forecast (2024-2030)” by IndustryARC, covers an in-depth analysis of the following segments in the GI Stool Testing Market.

Attribute

Segment

By Product Type

·       Reagents and Kits

·       Instruments and Analyzers

·       Software, and Services

By Test

·       Microscopy Test

·       Ovum Parasite Test

·       Culture Test

·       Bacteria Test

·       Occult Blood Test (Guaiac Fob Stool Test, Immuno-Fob Agglutination Test, Lateral Flow Immuno-Fob Test, Immuno-Fob Elisa Test)

·       Stool Biomarkers Test (Cologuard, M2-Pk Stool Test),

By Application

·       Infection

·       Inflammatory Bowel Disease (IBD)

·       Gastroesophageal Reflux Disease

·       Cancer

·       Others

By Distribution Channel

·       Hospitals & Clinics Pharmacies

·       Brick & Mortar

·       E-Commerce

By End User

·       Hospital

·       Diagnostic Centre and Laboratory

·       Academic Institution

·       Research Centre Organization

·       Homecare

·       Others

By Geography

·       North America

·       South America

·       Europe

·       APAC

·       Row

COVID-19 / Ukraine Crisis - Impact Analysis:  

The COVID-19 pandemic had significant adverse impacts on the GI stool testing industry. Lockdowns and supply chain interruptions caused a decrease in the production and distribution of diagnostic tests in the healthcare sector. However, the business is starting to recover as a result of the increased demand for data-driven decision-making in the post-pandemic climate. The market for GI stool testing is rebounding because businesses are depending more and more on data analytics to control risks, optimize workflows, and boost productivity. Technological advancements and a focus on bolstering business resilience are expected to define future trends, with advances in artificial intelligence and molecular diagnostics expected to play significant roles in this comeback.

The Ukraine crisis has significantly disrupted global supply chains, impacting the GI Stool Testing market. Due to raw material shortages and increased transportation costs brought on by the conflict, the price of diagnostic products has increased and their delivery has been delayed. This instability has compelled businesses to change their strategies and search for other suppliers to maintain a consistent supply and a stable market. Major firms are responding to these issues by investing in advanced data analytics, diversifying their supply chains, and exploring new supply options to better anticipate and respond to market volatility. These actions are necessary to lessen the impact of supply chain disruptions and maintain GI accessibility.

Key Takeaways:

Fastest Growth of APAC Region

Geographically, in the GI Stool Testing Market share, APAC is analyzed to grow with the highest CAGR of 9.8% during the forecast period 2024-2030. This strong rise is attributed to a number of things. First off, the need for sophisticated diagnostic tests is being fueled by the rising incidence of gastrointestinal disorders in APAC, which is being caused by altered eating and lifestyle patterns. For instance, in 2023, a high 13 to 14% annual growth rate is being experienced by the $6 billion laboratory diagnostics business in India. Furthermore, the region's expanding diagnostic service availability and accessibility are improved by the substantial governmental and private sector expenditures in the healthcare infrastructure. The growing understanding of the significance of early detection and prevention of gastrointestinal disorders is another motivating reason. The industry is being further supported by government and healthcare organization initiatives to encourage routine health check-ups. Additionally, the use of cutting-edge diagnostic instruments and improvements in medical technology are increasing the effectiveness and accessibility of GI stool testing.

Hospitals Segment to Register the Fastest Growth

In the GI Stool Testing Market analysis, the hospital segment is estimated to grow with the highest CAGR of 9.1% during the forecast period. The industry with the fastest growth potential among them is expected to be hospitals and clinics. The rising incidence of gastrointestinal disorders, the development of hospital infrastructure, and the growing use of cutting-edge diagnostic tools in clinical settings are the main causes of this explosive growth. Comprehensive testing services, such as modern GI stool testing, are offered by hospitals and clinics to guarantee precise diagnosis and efficient patient care. This segment's dominance and rapid expansion in the GI stool testing market are further supported by the emphasis on enhancing patient outcomes and healthcare services. The accuracy and effectiveness of GI stool tests, such as occult blood tests and stool biomarkers testing, which are essential for identifying diseases like colorectal cancer, are improved by the incorporation of cutting-edge diagnostic technology in these contexts. The development of healthcare infrastructure also contributes to this segment's growth, especially in emerging nations. More patients will be able to receive the necessary diagnostic testing because of improved access to healthcare facilities, which will increase demand.

Occult Blood Test segment is Leading the Market

According to the GI Stool Testing Market forecast, occult blood tests held the largest market valuation of $510 million in 2023. The market for GI stool testing is currently being led by the Occult Blood Test sector because of its crucial significance in the early diagnosis and identification of gastrointestinal disorders, especially colorectal cancer. An early warning sign of colorectal cancer or other gastrointestinal problems such as ulcers, polyps, and inflammatory bowel illnesses can be found with the fecal occult blood test (FOBT), which looks for concealed blood in the stool. Because FOBT provides early detection and greatly enhances treatment results and survival rates, it is the method of choice for regular screening. According to PLOS Global Public Health 2023, comparing the innovator's FOBT product to stringent invasive pathogen recovery, it was 62.5% and 81.6% sensitive and specific, respectively, whereas occult blood detection by microscopy was 55.6% sensitive and 78.4% specific. The dominance of this category is further reinforced by government initiatives encouraging early diagnosis and raising awareness of colorectal cancer screening programs. The aging population and the increasing incidence of gastrointestinal illnesses are two further factors driving the demand for FOBTs. Occult blood tests have become more reliable because to technological developments in test sensitivity and accuracy, which have led to their widespread use in clinical and home settings.

Rising Prevalence of Gastrointestinal Disorders

The rising incidence of gastrointestinal (GI) problems, including colorectal cancer, irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD), is one of the main factors propelling the market for GI stool testing. There is an increasing need for efficient diagnostic instruments, such as GI stool tests, as the prevalence of these disorders rises. In particular, colorectal cancer has grown to be a major global health concern, which has led medical professionals to stress early identification and routine screenings. GI stool diagnostics, like stool DNA tests and fecal occult blood tests (FOBT), are essential in spotting early indicators of colorectal cancer and improving patient outcomes by acting quickly to treat the condition. The general public's rising knowledge of the value of preventative care and gastrointestinal health also contributes to the need for GI stool testing. The global healthcare systems' emphasis on the prompt identification and treatment of gastrointestinal illnesses is anticipated to sustain the GI stool testing market's strong expansion.

Technological Advancements in Diagnostic Testing  

Another significant factor driving the GI stool testing market is technological developments in diagnostic testing. The development of extremely specific and sensitive stool DNA testing is one example of how advances in molecular diagnostics have greatly improved the accuracy and dependability of GI stool tests. These developments make it possible to identify minute genetic alterations and biomarkers linked to gastrointestinal disorders, enabling earlier and more accurate diagnosis. Furthermore, the analysis and interpretation of test results have been further enhanced by the incorporation of artificial intelligence (AI) and machine learning (ML) in diagnostic platforms, improving clinical decision-making. Wider acceptance of GI stool tests has been encouraged by the development of non-invasive testing techniques, which have also improved patient comfort. The capabilities and applications of GI stool testing are anticipated to improve as technology advances, propelling market expansion and enhancing patient care.

Intense Market Competition is a Major Challenge

Intense competition is one of the major issues facing the GI stool testing sector. There are many competitors fighting for market share in this congested field, from well-known diagnostic companies to up-and-coming startups. Because of the intense competition, prices may drop and businesses' profit margins may be squeezed. To differentiate their products and keep ahead of the competition, businesses must also constantly innovate, which necessitates a significant expenditure in research and development (R&D). The competitive landscape is further heightened by the speed at which technology is developing. To provide cutting-edge products, businesses need to stay abreast of the newest advancements in diagnostic technology, such as artificial intelligence (AI) and molecular diagnostics. Resources may be stretched by this demand for continual innovation, particularly for smaller businesses with tighter budgets. Furthermore, the need to get permits for new products and regulatory obstacles may prolong the time to market, giving competitors an advantage.

For More Details on This Report - Request for Sample
  

Key Market Players: 

Product/Service launches, approvals, patents and events, acquisitions, partnerships, and collaborations are key strategies adopted by players in the GI Stool Testing Market. The top 10 companies in this industry are listed below:

  1. Bio-Rad Laboratory 
  2. Biomrieux Inc 
  3. Cenogenics Corporation 
  4. Diasorin S P A 
  5. Meridian Bioscience Inc 
  6. Quest Diagnostics Incorporated 
  7. Siemens Healthcare 
  8. Epitope Diagnostics Inc
  9. Cardinal Health
  10. ScheBo Biotech AG

Scope of the Report: 

Report Metric

Details

Base Year Considered

2023

Forecast Period

2024–2030

CAGR

7.7%

Market Size in 2030

$932.8 million

Segments Covered

By Product Type, By Test, By Application, By Distribution Channel, By End User, and Geography.

Geographies Covered

North America, South America, Europe, APAC, RoW.

Key Market Players

1.     Bio-Rad Laboratory

2.     Biomrieux Inc

3.     Cenogenics Corporation

4.     Diasorin S P A

5.     Meridian Bioscience Inc

6.     Quest Diagnostics Incorporated

7.     Siemens Healthcare

8.     Epitope Diagnostics Inc

9.     Cardinal Health

10.  ScheBo Biotech AG

For more Lifesciences and Healthcare Market reports, please click here

1. GI Stool Testing Market - Overview
    1.1. Market Definition  
    1.2. Market Scope  
2. GI Stool Testing Market - Executive Summary
3. GI Stool Testing Market - Comparative Analysis
    3.1. Company Benchmarking - Key Companies
    3.2. Financial Analysis - Key Companies
    3.3. Market Share Analysis - Key Companies
    3.4. Patent Analysis
    3.5. Pricing Analysis
4. GI Stool Testing Market - Start-up Companies Scenario
    4.1. Key Start-up Company Analysis by
        4.1.1. Investment & Revenue
        4.1.2. Venture Capital and Funding Scenario
5. GI Stool Testing Market – Market Entry Scenario Premium
    5.1. Regulatory Framework Overview
    5.2. New Business and Ease of Doing Business Index
    5.3. Case Studies of Successful Ventures
6. GI Stool Testing Market - Forces
    6.1. Market Drivers
    6.2. Market Constraints
    6.3. Market Challenges
    6.4. Porter's Five Force Model
        6.4.1. Bargaining Power of Suppliers
        6.4.2. Bargaining Powers of Customers
        6.4.3. Threat of New Entrants
        6.4.4. Rivalry Among Existing Players
        6.4.5. Threat of Substitutes
7. GI Stool Testing Market – Strategic Analysis
    7.1. Value Chain Analysis
    7.2. Opportunities Analysis
    7.3. Market Life Cycle
8. GI Stool Testing Market – By Product Type (Market Size – $Million/$Billion) 
    8.1. Reagents and Kits
    8.2. Instruments and Analyzers
    8.3. Software, and Services
9. GI Stool Testing Market – By Test (Market Size – $Million/$Billion) 
    9.1. Microscopy Test
    9.2. Ovum Parasite Test
    9.3. Culture Test
    9.4. Bacteria Test
    9.5. Occult Blood Test
        9.5.1. Guaiac Fob Stool Test
        9.5.2. Immuno-Fob Agglutination Test
        9.5.3. Lateral Flow Immuno-Fob Test
        9.5.4. Immuno-Fob Elisa Test
    9.6. Stool Biomarkers Test
        9.6.1. Cologuard
        9.6.2. M2-Pk Stool Test
10. GI Stool Testing Market – By Application (Market Size – $Million/$Billion) 
    10.1. Infections
    10.2. Inflammatory Bowel Disease (IBD)
    10.3. Gastroesophageal Reflux Disease
    10.4. Cancer
    10.5. Others
11. GI Stool Testing Market – By Distribution Channel (Market Size – $Million/$Billion) 
    11.1. Hospitals & Clinics Pharmacies
    11.2. Brick & Mortar
    11.3. E-Commerce
12. GI Stool Testing Market – By End-user (Market Size – $Million/$Billion)
    12.1. Hospital
    12.2. Diagnostic Centre and Laboratory
    12.3. Academic Institution
    12.4. Research Centre Organization
    12.5. Homecare
    12.6. Others 
13. GI Stool Testing Market – by Geography (Market Size – $Million/$Billion) 
    13.1. North America
        13.1.1. U.S
        13.1.2. Canada
        13.1.3. Mexico
    13.2. Europe
        13.2.1. Germany
        13.2.2. France
        13.2.3. UK
        13.2.4. Italy
        13.2.5. Spain
        13.2.6. Belgium
        13.2.7. Netherlands
        13.2.8. Rest of Europe
    13.3. Asia-Pacific
        13.3.1. China
        13.3.2. Japan
        13.3.3. South Korea
        13.3.4. India
        13.3.5. Australia & New Zealand
        13.3.6. Indonesia
        13.3.7. Malaysia
        13.3.8. Taiwan
        13.3.9. Rest of Asia-Pacific
    13.4. South America
        13.4.1. Brazil
        13.4.2. Argentina
        13.4.3. Chile
        13.4.4. Colombia
        13.4.5. Rest of South America
    13.5. Rest of The World
        13.5.1. Middle East
        13.5.2. Africa
14. GI Stool Testing Market – Entropy
15. GI Stool Testing Market – Industry/Segment Competition Landscape
    15.1. Global Market Share Analysis by Region 
    15.2. Global Market Share Analysis by Country 
    15.3. Global Market Share Analysis by Type
16. GI Stool Testing Market – Key Company List by Country Premium
17. GI Stool Testing Market - Company Analysis
    17.1. Bio-Rad Laboratory 
    17.2. Biomrieux Inc 
    17.3. Cenogenics Corporation 
    17.4. Diasorin S P A 
    17.5. Meridian Bioscience Inc 
    17.6. Quest Diagnostics Incorporated 
    17.7. Siemens Healthcare 
    17.8. Epitope Diagnostics Inc
    17.9. Cardinal Health
    17.10. ScheBo Biotech AG

LIST OF TABLES

1.Global Gi Stool Testing Market, By Test Market 2023-2030 ($M)
1.1 Microscopy Test Market 2023-2030 ($M) - Global Industry Research
1.2 Ovum Parasite Test Market 2023-2030 ($M) - Global Industry Research
1.3 Culture Test Market 2023-2030 ($M) - Global Industry Research
1.4 Bacteria Test Market 2023-2030 ($M) - Global Industry Research
1.5 Occult Blood Test Market 2023-2030 ($M) - Global Industry Research
1.5.1 Guaiac Fob Stool Test Market 2023-2030 ($M)
1.5.2 Immuno-Fob Agglutination Test Market 2023-2030 ($M)
1.5.3 Lateral Flow Immuno-Fob Test Market 2023-2030 ($M)
1.5.4 Immuno-Fob Elisa Test Market 2023-2030 ($M)
1.6 Stool Biomarkers Test Market 2023-2030 ($M) - Global Industry Research
1.6.1 Cologuard Market 2023-2030 ($M)
1.6.2 M2-Pk Stool Test Market 2023-2030 ($M)
2.Global Gi Stool Testing Market, By Product Type Market 2023-2030 ($M)
2.1 Reagent Market 2023-2030 ($M) - Global Industry Research
2.2 Instrument Market 2023-2030 ($M) - Global Industry Research
3.Global Gi Stool Testing Market, By End-User Market 2023-2030 ($M)
3.1 Hospital Market 2023-2030 ($M) - Global Industry Research
3.2 Diagnostic Centre And Laboratory Market 2023-2030 ($M) - Global Industry Research
3.3 Academic Institution Market 2023-2030 ($M) - Global Industry Research
3.4 Research Centre Organization Market 2023-2030 ($M) - Global Industry Research
3.5 Home Market 2023-2030 ($M) - Global Industry Research
4.Global Gi Stool Testing Market, By Test Market 2023-2030 (Volume/Units)
4.1 Microscopy Test Market 2023-2030 (Volume/Units) - Global Industry Research
4.2 Ovum Parasite Test Market 2023-2030 (Volume/Units) - Global Industry Research
4.3 Culture Test Market 2023-2030 (Volume/Units) - Global Industry Research
4.4 Bacteria Test Market 2023-2030 (Volume/Units) - Global Industry Research
4.5 Occult Blood Test Market 2023-2030 (Volume/Units) - Global Industry Research
4.5.1 Guaiac Fob Stool Test Market 2023-2030 (Volume/Units)
4.5.2 Immuno-Fob Agglutination Test Market 2023-2030 (Volume/Units)
4.5.3 Lateral Flow Immuno-Fob Test Market 2023-2030 (Volume/Units)
4.5.4 Immuno-Fob Elisa Test Market 2023-2030 (Volume/Units)
4.6 Stool Biomarkers Test Market 2023-2030 (Volume/Units) - Global Industry Research
4.6.1 Cologuard Market 2023-2030 (Volume/Units)
4.6.2 M2-Pk Stool Test Market 2023-2030 (Volume/Units)
5.Global Gi Stool Testing Market, By Product Type Market 2023-2030 (Volume/Units)
5.1 Reagent Market 2023-2030 (Volume/Units) - Global Industry Research
5.2 Instrument Market 2023-2030 (Volume/Units) - Global Industry Research
6.Global Gi Stool Testing Market, By End-User Market 2023-2030 (Volume/Units)
6.1 Hospital Market 2023-2030 (Volume/Units) - Global Industry Research
6.2 Diagnostic Centre And Laboratory Market 2023-2030 (Volume/Units) - Global Industry Research
6.3 Academic Institution Market 2023-2030 (Volume/Units) - Global Industry Research
6.4 Research Centre Organization Market 2023-2030 (Volume/Units) - Global Industry Research
6.5 Home Market 2023-2030 (Volume/Units) - Global Industry Research
7.North America Gi Stool Testing Market, By Test Market 2023-2030 ($M)
7.1 Microscopy Test Market 2023-2030 ($M) - Regional Industry Research
7.2 Ovum Parasite Test Market 2023-2030 ($M) - Regional Industry Research
7.3 Culture Test Market 2023-2030 ($M) - Regional Industry Research
7.4 Bacteria Test Market 2023-2030 ($M) - Regional Industry Research
7.5 Occult Blood Test Market 2023-2030 ($M) - Regional Industry Research
7.5.1 Guaiac Fob Stool Test Market 2023-2030 ($M)
7.5.2 Immuno-Fob Agglutination Test Market 2023-2030 ($M)
7.5.3 Lateral Flow Immuno-Fob Test Market 2023-2030 ($M)
7.5.4 Immuno-Fob Elisa Test Market 2023-2030 ($M)
7.6 Stool Biomarkers Test Market 2023-2030 ($M) - Regional Industry Research
7.6.1 Cologuard Market 2023-2030 ($M)
7.6.2 M2-Pk Stool Test Market 2023-2030 ($M)
8.North America Gi Stool Testing Market, By Product Type Market 2023-2030 ($M)
8.1 Reagent Market 2023-2030 ($M) - Regional Industry Research
8.2 Instrument Market 2023-2030 ($M) - Regional Industry Research
9.North America Gi Stool Testing Market, By End-User Market 2023-2030 ($M)
9.1 Hospital Market 2023-2030 ($M) - Regional Industry Research
9.2 Diagnostic Centre And Laboratory Market 2023-2030 ($M) - Regional Industry Research
9.3 Academic Institution Market 2023-2030 ($M) - Regional Industry Research
9.4 Research Centre Organization Market 2023-2030 ($M) - Regional Industry Research
9.5 Home Market 2023-2030 ($M) - Regional Industry Research
10.South America Gi Stool Testing Market, By Test Market 2023-2030 ($M)
10.1 Microscopy Test Market 2023-2030 ($M) - Regional Industry Research
10.2 Ovum Parasite Test Market 2023-2030 ($M) - Regional Industry Research
10.3 Culture Test Market 2023-2030 ($M) - Regional Industry Research
10.4 Bacteria Test Market 2023-2030 ($M) - Regional Industry Research
10.5 Occult Blood Test Market 2023-2030 ($M) - Regional Industry Research
10.5.1 Guaiac Fob Stool Test Market 2023-2030 ($M)
10.5.2 Immuno-Fob Agglutination Test Market 2023-2030 ($M)
10.5.3 Lateral Flow Immuno-Fob Test Market 2023-2030 ($M)
10.5.4 Immuno-Fob Elisa Test Market 2023-2030 ($M)
10.6 Stool Biomarkers Test Market 2023-2030 ($M) - Regional Industry Research
10.6.1 Cologuard Market 2023-2030 ($M)
10.6.2 M2-Pk Stool Test Market 2023-2030 ($M)
11.South America Gi Stool Testing Market, By Product Type Market 2023-2030 ($M)
11.1 Reagent Market 2023-2030 ($M) - Regional Industry Research
11.2 Instrument Market 2023-2030 ($M) - Regional Industry Research
12.South America Gi Stool Testing Market, By End-User Market 2023-2030 ($M)
12.1 Hospital Market 2023-2030 ($M) - Regional Industry Research
12.2 Diagnostic Centre And Laboratory Market 2023-2030 ($M) - Regional Industry Research
12.3 Academic Institution Market 2023-2030 ($M) - Regional Industry Research
12.4 Research Centre Organization Market 2023-2030 ($M) - Regional Industry Research
12.5 Home Market 2023-2030 ($M) - Regional Industry Research
13.Europe Gi Stool Testing Market, By Test Market 2023-2030 ($M)
13.1 Microscopy Test Market 2023-2030 ($M) - Regional Industry Research
13.2 Ovum Parasite Test Market 2023-2030 ($M) - Regional Industry Research
13.3 Culture Test Market 2023-2030 ($M) - Regional Industry Research
13.4 Bacteria Test Market 2023-2030 ($M) - Regional Industry Research
13.5 Occult Blood Test Market 2023-2030 ($M) - Regional Industry Research
13.5.1 Guaiac Fob Stool Test Market 2023-2030 ($M)
13.5.2 Immuno-Fob Agglutination Test Market 2023-2030 ($M)
13.5.3 Lateral Flow Immuno-Fob Test Market 2023-2030 ($M)
13.5.4 Immuno-Fob Elisa Test Market 2023-2030 ($M)
13.6 Stool Biomarkers Test Market 2023-2030 ($M) - Regional Industry Research
13.6.1 Cologuard Market 2023-2030 ($M)
13.6.2 M2-Pk Stool Test Market 2023-2030 ($M)
14.Europe Gi Stool Testing Market, By Product Type Market 2023-2030 ($M)
14.1 Reagent Market 2023-2030 ($M) - Regional Industry Research
14.2 Instrument Market 2023-2030 ($M) - Regional Industry Research
15.Europe Gi Stool Testing Market, By End-User Market 2023-2030 ($M)
15.1 Hospital Market 2023-2030 ($M) - Regional Industry Research
15.2 Diagnostic Centre And Laboratory Market 2023-2030 ($M) - Regional Industry Research
15.3 Academic Institution Market 2023-2030 ($M) - Regional Industry Research
15.4 Research Centre Organization Market 2023-2030 ($M) - Regional Industry Research
15.5 Home Market 2023-2030 ($M) - Regional Industry Research
16.APAC Gi Stool Testing Market, By Test Market 2023-2030 ($M)
16.1 Microscopy Test Market 2023-2030 ($M) - Regional Industry Research
16.2 Ovum Parasite Test Market 2023-2030 ($M) - Regional Industry Research
16.3 Culture Test Market 2023-2030 ($M) - Regional Industry Research
16.4 Bacteria Test Market 2023-2030 ($M) - Regional Industry Research
16.5 Occult Blood Test Market 2023-2030 ($M) - Regional Industry Research
16.5.1 Guaiac Fob Stool Test Market 2023-2030 ($M)
16.5.2 Immuno-Fob Agglutination Test Market 2023-2030 ($M)
16.5.3 Lateral Flow Immuno-Fob Test Market 2023-2030 ($M)
16.5.4 Immuno-Fob Elisa Test Market 2023-2030 ($M)
16.6 Stool Biomarkers Test Market 2023-2030 ($M) - Regional Industry Research
16.6.1 Cologuard Market 2023-2030 ($M)
16.6.2 M2-Pk Stool Test Market 2023-2030 ($M)
17.APAC Gi Stool Testing Market, By Product Type Market 2023-2030 ($M)
17.1 Reagent Market 2023-2030 ($M) - Regional Industry Research
17.2 Instrument Market 2023-2030 ($M) - Regional Industry Research
18.APAC Gi Stool Testing Market, By End-User Market 2023-2030 ($M)
18.1 Hospital Market 2023-2030 ($M) - Regional Industry Research
18.2 Diagnostic Centre And Laboratory Market 2023-2030 ($M) - Regional Industry Research
18.3 Academic Institution Market 2023-2030 ($M) - Regional Industry Research
18.4 Research Centre Organization Market 2023-2030 ($M) - Regional Industry Research
18.5 Home Market 2023-2030 ($M) - Regional Industry Research
19.MENA Gi Stool Testing Market, By Test Market 2023-2030 ($M)
19.1 Microscopy Test Market 2023-2030 ($M) - Regional Industry Research
19.2 Ovum Parasite Test Market 2023-2030 ($M) - Regional Industry Research
19.3 Culture Test Market 2023-2030 ($M) - Regional Industry Research
19.4 Bacteria Test Market 2023-2030 ($M) - Regional Industry Research
19.5 Occult Blood Test Market 2023-2030 ($M) - Regional Industry Research
19.5.1 Guaiac Fob Stool Test Market 2023-2030 ($M)
19.5.2 Immuno-Fob Agglutination Test Market 2023-2030 ($M)
19.5.3 Lateral Flow Immuno-Fob Test Market 2023-2030 ($M)
19.5.4 Immuno-Fob Elisa Test Market 2023-2030 ($M)
19.6 Stool Biomarkers Test Market 2023-2030 ($M) - Regional Industry Research
19.6.1 Cologuard Market 2023-2030 ($M)
19.6.2 M2-Pk Stool Test Market 2023-2030 ($M)
20.MENA Gi Stool Testing Market, By Product Type Market 2023-2030 ($M)
20.1 Reagent Market 2023-2030 ($M) - Regional Industry Research
20.2 Instrument Market 2023-2030 ($M) - Regional Industry Research
21.MENA Gi Stool Testing Market, By End-User Market 2023-2030 ($M)
21.1 Hospital Market 2023-2030 ($M) - Regional Industry Research
21.2 Diagnostic Centre And Laboratory Market 2023-2030 ($M) - Regional Industry Research
21.3 Academic Institution Market 2023-2030 ($M) - Regional Industry Research
21.4 Research Centre Organization Market 2023-2030 ($M) - Regional Industry Research
21.5 Home Market 2023-2030 ($M) - Regional Industry Research

LIST OF FIGURES

1.US GI Stool Testing Market Revenue, 2023-2030 ($M)
2.Canada GI Stool Testing Market Revenue, 2023-2030 ($M)
3.Mexico GI Stool Testing Market Revenue, 2023-2030 ($M)
4.Brazil GI Stool Testing Market Revenue, 2023-2030 ($M)
5.Argentina GI Stool Testing Market Revenue, 2023-2030 ($M)
6.Peru GI Stool Testing Market Revenue, 2023-2030 ($M)
7.Colombia GI Stool Testing Market Revenue, 2023-2030 ($M)
8.Chile GI Stool Testing Market Revenue, 2023-2030 ($M)
9.Rest of South America GI Stool Testing Market Revenue, 2023-2030 ($M)
10.UK GI Stool Testing Market Revenue, 2023-2030 ($M)
11.Germany GI Stool Testing Market Revenue, 2023-2030 ($M)
12.France GI Stool Testing Market Revenue, 2023-2030 ($M)
13.Italy GI Stool Testing Market Revenue, 2023-2030 ($M)
14.Spain GI Stool Testing Market Revenue, 2023-2030 ($M)
15.Rest of Europe GI Stool Testing Market Revenue, 2023-2030 ($M)
16.China GI Stool Testing Market Revenue, 2023-2030 ($M)
17.India GI Stool Testing Market Revenue, 2023-2030 ($M)
18.Japan GI Stool Testing Market Revenue, 2023-2030 ($M)
19.South Korea GI Stool Testing Market Revenue, 2023-2030 ($M)
20.South Africa GI Stool Testing Market Revenue, 2023-2030 ($M)
21.North America GI Stool Testing By Application
22.South America GI Stool Testing By Application
23.Europe GI Stool Testing By Application
24.APAC GI Stool Testing By Application
25.MENA GI Stool Testing By Application
26.Biomrieux Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Meridian Bioscience Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Diasorin S P A, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Beckman Coulter Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Alere Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Bio-Rad Laboratory, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Cenogenics Corporation, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Siemens Healthcare, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Quest Diagnostics Incorporated, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Abbott Laboratory, Sales /Revenue, 2015-2018 ($Mn/$Bn)

The GI Stool Testing Market is projected to grow at 7.7% CAGR during the forecast period 2024-2030.

GI Stool Testing Market size is estimated to be $555 million in 2023 and is projected to reach $932.8 million by 2030.

The leading players in the GI Stool Testing Market are Bio-Rad Laboratory, Biomrieux Inc., Cenogenics Corporation, Diasorin S P A, Meridian Bioscience Inc. and Others.

Growing demand in emerging markets, expansion of preventive healthcare programs, and growing healthcare expenditure and government initiatives which will create growth opportunities for the market during the forecast period.

The rising prevalence of gastrointestinal disorders and technological advancements in diagnostic testing are the driving factors of the market.